2009-April 15 - NeoStem, Inc. Announces Agreement With Progenitor Cell Therapy, LLC. NEW YORK (PRNewswire-FirstCall)
2007 September 17 -- MicroIslet and Progenitor Cell Therapy Enter Into Agreement for the Manufacturing of MicroIslet-P, an Encapsulated Islet Cell Product for the Treatment of Type 1 Diabetes. SAN DIEGO and HACKENSACK, N.J. (PRIME NEWSWIRE)